Celularity, Inc. (CELU)
1.60
+0.22
(+15.94%)
USD |
NASDAQ |
Oct 02, 16:00
1.60
0.00 (0.00%)
After-Hours: 20:00
Celularity Enterprise Value : 114.40M for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 114.40M |
| October 01, 2026 | 107.98M |
| September 30, 2026 | 107.10M |
| September 29, 2026 | 107.69M |
| September 28, 2026 | 108.56M |
| September 25, 2026 | 107.98M |
| September 24, 2026 | 106.23M |
| September 23, 2026 | 101.27M |
| September 22, 2026 | 102.14M |
| September 21, 2026 | 103.90M |
| September 18, 2026 | 105.94M |
| September 17, 2026 | 104.77M |
| September 16, 2026 | 105.35M |
| September 15, 2026 | 103.90M |
| September 14, 2026 | 108.56M |
| September 11, 2026 | 108.86M |
| September 10, 2026 | 109.58M |
| September 09, 2026 | 109.73M |
| September 08, 2026 | 112.65M |
| September 04, 2026 | 116.73M |
| September 03, 2026 | 121.11M |
| September 02, 2026 | 121.99M |
| September 01, 2026 | 122.57M |
| August 31, 2026 | 121.69M |
| August 28, 2026 | 113.82M |
| Date | Value |
|---|---|
| August 27, 2026 | 128.99M |
| August 26, 2026 | 93.40M |
| August 25, 2026 | 91.08M |
| August 24, 2026 | 90.32M |
| August 21, 2026 | 91.06M |
| August 20, 2026 | 90.09M |
| August 19, 2026 | 90.41M |
| August 18, 2026 | 89.21M |
| August 17, 2026 | 88.02M |
| August 14, 2026 | 88.02M |
| August 13, 2026 | 88.00M |
| August 12, 2026 | 87.85M |
| August 11, 2026 | 88.14M |
| August 10, 2026 | 87.75M |
| August 07, 2026 | 88.16M |
| August 06, 2026 | 87.64M |
| August 05, 2026 | 89.14M |
| August 04, 2026 | 88.24M |
| August 03, 2026 | 86.98M |
| July 31, 2026 | 86.25M |
| July 30, 2026 | 87.55M |
| July 29, 2026 | 87.27M |
| July 28, 2026 | 89.89M |
| July 27, 2026 | 89.63M |
| July 24, 2026 | 89.60M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Tenax Therapeutics, Inc. | -54.72M |
| Exicure, Inc. | 5.613M |
| Century Therapeutics, Inc. | 195.19M |
| Absci Corp. | 1.702B |
| Cardio Diagnostics Holdings, Inc. | 0.5836M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 0.675M |
| Revenue (Quarterly) | 3.846M |
| Total Expenses (Quarterly) | 3.171M |
| EPS Diluted (Quarterly) | 0.0223 |
| Gross Profit Margin (Quarterly) | 20.70% |
| Profit Margin (Quarterly) | 17.55% |
| Earnings Yield | -170.1% |
| Normalized Earnings Yield | -154.89 |